HBW Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China Coming Around To Animal Test Alternatives, Cruelty Free Says

This article was originally published in The Rose Sheet

Executive Summary

China revised its cosmetics regulations last year to allow domestic ordinary-use cosmetic manufacturers to substantiate safety without use of animal tests, and in many cases the exemption is being extended to importers, according to Cruelty Free International's Director of Policy Nick Palmer. He says cosmetics that are bottled or packaged in the country are being considered domestics exempt from animal-testing requirements under a "liberal interpretation" of the regulation.


Related Content

CFI Clarifies Cosmetics Pilot For Animal Testing-Free China Entry
China Pilot Program May Let Cosmetic Importers Bypass Animal Testing
In Brief: Cancer Society Endorses Feinstein Bill; Microbead Costs; More
TPP Cosmetics Annex Is 'Signal To The World' For Regulatory Best Practices
Cruelty Free: Advancing Humane Cosmetics Act Would Send Global Signal
Animal-Test Alternatives Progress In China Despite Regulatory Uncertainty

Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts